Cargando…
Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity
OBJECTIVE: Solid tumours respond poorly to immune checkpoint inhibitor (ICI) therapies. One major therapeutic obstacle is the immunosuppressive tumour microenvironment (TME). Cancer-associated fibroblasts (CAFs) are a key component of the TME and negatively regulate antitumour T-cell response. Here,...
Autores principales: | Huang, Tu-Xiong, Tan, Xiang-Yu, Huang, Hui-Si, Li, Yu-Ting, Liu, Bei-Lei, Liu, Kai-Sheng, Chen, Xinchun, Chen, Zhe, Guan, Xin-Yuan, Zou, Chang, Fu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762012/ https://www.ncbi.nlm.nih.gov/pubmed/33692094 http://dx.doi.org/10.1136/gutjnl-2020-322924 |
Ejemplares similares
-
Methionine deficiency facilitates antitumour immunity by altering m(6)A methylation of immune checkpoint transcripts
por: Li, Ting, et al.
Publicado: (2023) -
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers
por: Carotenuto, Pietro, et al.
Publicado: (2017) -
Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
por: Zhao, Yue, et al.
Publicado: (2018) -
Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis
por: Peignon, Grégory, et al.
Publicado: (2011) -
Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice
por: Kortüm, Benedikt, et al.
Publicado: (2015)